Indications and uses
Helps prevent sunburn
LBEL NATURAL FINISH MOISTURIZING FOUNDATION SPF 25
- Manufacturer
- Ventura Corporation LTD | Bel Star S.A. (Colombia)
- Effective date
- 2013-12-19
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- legacy-cache
- Hydrated at
- 2026-08-02 01:37:50
Label at a glance#
ProductLBEL NATURAL FINISH MOISTURIZING FOUNDATION SPF 25 (CLAIRE 1) - BEIGE
Active ingredientOctinoxate, Titanium Dioxide
Label structure24 sections
Dosage and administration
Apply liberally and evenly 15 minutes before sun exposure. Reapply at least every 2 hours Use a water resistant sunscreen if swimming or sweating. Children under 6 months of age: Ask a doctor
Storage and handling
Protect the product in this container from excessive heat and direct sun.
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
OTC - ACTIVE INGREDIENT SECTION
OTC - PURPOSE SECTION
| Active Ingredients | Purpose |
|---|---|
| Octinoxate 6.5 % | Sunscreen |
| Titanium Dioxide 1.6% | Sunscreen |
Uses
- Helps prevent sunburn
Warnings
- Skin Cancer / Skin Aging Alert: Spending time in the sun increases your risk of skin cancer and early skin aging.This product has been shown only to help prevent sunburn, not skin cancer or early skin aging.
OTC - WHEN USING SECTION
- For external use only.
OTC - DO NOT USE SECTION
- Do not use on damaged or broken skin.
OTC - WHEN USING SECTION
- When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
- Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
Directions
- Apply liberally and evenly 15 minutes before sun exposure.
- Reapply at least every 2 hours
- Use a water resistant sunscreen if swimming or sweating.
- Children under 6 months of age: Ask a doctor
Other information
- Protect the product in this container from excessive heat and direct sun.
Inactive ingredients
Water, cyclopentasiloxane, cyclohexasiloxane, propylene glycol dicaprylate/dicaprate, peg/ppg-18/18 dimethicone, trimethylsiloxysilicate, dimethicone/vinyl dimethicone crosspolymer, xylitylglucoside, octyldodecanol, oleth-5, polymethyl methacrylate, anhydroxylitol, glycerin, linoleic acid, peg/ppg-19/19 dimethicone, microcrystalline wax, c12-15 alkyl benzoate, xylitol, diazolidinyl urea, alumina, petrolatum, tocopheryl acetate, triethoxycaprylylsilane, phospholipids, ribes nigrum (black currant) seed oil, silica, methylparaben, propylparaben, fragrance, copernicia cerifera (carnauba) wax, tribehenin, cholesterol, methicone, bht, menthoxypropanediol, euphorbia cerifera (candelilla) wax, beeswax, cetearyl alcohol, cetearyl glucoside, polyglyceryl-2 dipolyhydroxystearate, glycosphingolipids, ceramide 2, decyl glucoside, linolenic acid, peg-10 rapeseed sterol, palmitoyl oligopeptide.
May contain:
Titanium dioxide, iron oxides , iron oxides, iron oxides.
SPL UNCLASSIFIED SECTION
PR: Distributed by Ventura Corporation, Ltd. San Juan, Puerto Rico 00926.
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Claire 1) - Beige
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Claire 2) - Beige
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Claire 3) - Beige
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Claire 4) - Beige
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Medium 5) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Medium 6) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Medium 7) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Obscure 8) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Obscure 9) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Medium 6A) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Medium 6B) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Obscure 8A) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Obscure 8B) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Obscure 8C) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Obscure 10) - Brown
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
PRINCIPAL DISPLAY PANEL - 30 mL Tube Carton - (Dore 6) - Beige
EFFET
PARFAIT
natural finish
moisturizing
foundation
SPF 25
30 ml e (1 fl.oz.)
L'BEL
FDA-Initiated Inactive NDC Indexing#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| .alpha.-tocopherol acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| 3-((l-menthyl)oxy)propane-1,2-diol | INACTIVE INGREDIENT | KD6TZ2QICH | 1 | |
| alkyl (c12-15) benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| aluminum oxide | INACTIVE INGREDIENT | LMI26O6933 | 1 | |
| anhydroxylitol | INACTIVE INGREDIENT | 8XWR7NN42F | 1 | |
| butylated hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| candelilla wax | INACTIVE INGREDIENT | WL0328HX19 | 1 | |
| carnauba wax | INACTIVE INGREDIENT | R12CBM0EIZ | 1 | |
| ceramide 2 | INACTIVE INGREDIENT | C04977SRJ5 | 1 | |
| cetearyl glucoside | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| cetostearyl alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| cholesterol | INACTIVE INGREDIENT | 97C5T2UQ7J | 1 | |
| cyclomethicone 5 | INACTIVE INGREDIENT | 0THT5PCI0R | 1 | |
| cyclomethicone 6 | INACTIVE INGREDIENT | XHK3U310BA | 1 | |
| decyl glucoside | INACTIVE INGREDIENT | Z17H97EA6Y | 1 | |
| diazolidinyl urea | INACTIVE INGREDIENT | H5RIZ3MPW4 | 1 | |
| ferric oxide red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| linoleic acid | INACTIVE INGREDIENT | 9KJL21T0QJ | 1 | |
| linolenic acid | INACTIVE INGREDIENT | 0RBV727H71 | 1 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| microcrystalline wax | INACTIVE INGREDIENT | XOF597Q3KY | 1 | |
| octyldodecanol | INACTIVE INGREDIENT | 461N1O614Y | 1 | |
| oleth-5 | INACTIVE INGREDIENT | 1GH33785AY | 1 | |
| palmitoyl oligopeptide | INACTIVE INGREDIENT | HO4ZT5S86C | 1 | |
| peg-10 rapeseed sterol | INACTIVE INGREDIENT | 258O76T85M | 1 | |
| peg/ppg-18/18 dimethicone | INACTIVE INGREDIENT | 9H0AO7T794 | 1 | |
| peg/ppg-19/19 dimethicone | INACTIVE INGREDIENT | EHH90CO7TL | 1 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| polyglyceryl-2 dipolyhydroxystearate | INACTIVE INGREDIENT | 9229XJ4V12 | 1 | |
| propylene glycol dicaprylate/dicaprate | INACTIVE INGREDIENT | O4446S9CRA | 1 | |
| propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 1 | |
| ribes nigrum seed oil | INACTIVE INGREDIENT | GKE1188837 | 1 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| tribehenin | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| xylitol | INACTIVE INGREDIENT | VCQ006KQ1E | 1 | |
| xylitylglucoside | INACTIVE INGREDIENT | O0IEZ166FB | 1 | |
| yellow wax | INACTIVE INGREDIENT | 2ZA36H0S2V | 1 |
Products#
Every source-derived product name is available through these pages.
- LBEL NATURAL FINISH MOISTURIZING FOUNDATION SPF 25 (CLAIRE 1) - BEIGE
- Octinoxate and Titanium Dioxide
- Octinoxate
- Titanium Dioxide
- water
- cyclomethicone 5
- cyclomethicone 6
- propylene glycol dicaprylate/dicaprate
- peg/ppg-18/18 dimethicone
- xylitylglucoside
- octyldodecanol
- oleth-5
- anhydroxylitol
- glycerin
- linoleic acid
- peg/ppg-19/19 dimethicone
- microcrystalline wax
- alkyl (c12-15) benzoate
- xylitol
- diazolidinyl urea
- aluminum oxide
- petrolatum
- .alpha.-tocopherol acetate
- triethoxycaprylylsilane
- ribes nigrum seed oil
- silicon dioxide
- methylparaben
- propylparaben
- carnauba wax
- tribehenin
- cholesterol
- butylated hydroxytoluene
- 3-((l-menthyl)oxy)propane-1,2-diol
- candelilla wax
- yellow wax
- cetostearyl alcohol
- cetearyl glucoside
- polyglyceryl-2 dipolyhydroxystearate
- ceramide 2
- decyl glucoside
NDC Codes#
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| glycerin | GLYCERIN | PDC6A3C0OX | MOUTHWASH / BUCCAL | 100 mg/1ml | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SHAMPOO, SUSPENSION / TOPICAL | 0.15 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg | ||
| octyldodecanol | OCTYLDODECANOL | 461N1O614Y | LOTION / TOPICAL | 714 mg | ||
| cholesterol | CHOLESTEROL | 97C5T2UQ7J | INJECTION / INTRAVENOUS | 93 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | 388 mg | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SPRAY, METERED / NASAL | 0.1 mg/1ml | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET, EXTENDED RELEASE / ORAL | 0.12 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | EMULSION / TOPICAL | 0.2 %w/w | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | SUSPENSION, EXTENDED RELEASE / ORAL | 2.7 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, COATED / ORAL | 176 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SOLUTION / ORAL | 126 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | LIQUID / TOPICAL | 0.1 %w/w | ||
| .alpha.-tocopherol acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | INJECTION, SOLUTION / INTRAMUSCULAR | 5 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| microcrystalline wax | MICROCRYSTALLINE WAX | XOF597Q3KY | CAPSULE, EXTENDED RELEASE / ORAL | 6 mg | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 140 mg | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION / INTRAVENOUS | NA | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | CREAM / TOPICAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / RESPIRATORY (INHALATION) | 5 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE / ORAL | 5000 mg | ||
| cetostearyl alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | AEROSOL, FOAM / TOPICAL | 21 mg | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | GEL, METERED / TOPICAL | 4 mg | ||
| xylitol | XYLITOL | VCQ006KQ1E | POWDER, FOR SUSPENSION / ORAL | 4223 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| xylitol | XYLITOL | VCQ006KQ1E | SUSPENSION / ORAL | 1500 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CREAM / VAGINAL | 3 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | SPONGE / TOPICAL | NA | ||
| cholesterol | CHOLESTEROL | 97C5T2UQ7J | OINTMENT / TOPICAL | 5 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / IRRIGATION | 2 %w/v | ||
| glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| butylated hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, ORALLY DISINTEGRATING / ORAL | 1 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | OINTMENT / OPHTHALMIC | 0.01 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAVENOUS | 95 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / ORAL | 100 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | FILM / BUCCAL | 1 mg | ||
| xylitol | XYLITOL | VCQ006KQ1E | SPRAY / SUBLINGUAL | 22 mg | ||
| xylitol | XYLITOL | VCQ006KQ1E | GUM, CHEWING / BUCCAL | 11915 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | OINTMENT / TOPICAL | 29 mg | ||
| yellow wax | YELLOW WAX | 2ZA36H0S2V | TABLET, DELAYED RELEASE / ORAL | 0.1 mg | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | TABLET, SUGAR COATED / ORAL | NA | ||
| carnauba wax | CARNAUBA WAX | R12CBM0EIZ | CAPSULE, EXTENDED RELEASE / ORAL | 288 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| ferric oxide red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SOLUTION / RESPIRATORY (INHALATION) | 0.01 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER, FOR SUSPENSION / ORAL | 2553 mg | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUSPENSION / ORAL | 64 mg | ||
| glycerin | GLYCERIN | PDC6A3C0OX | JELLY / TOPICAL | NA | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER / ORAL | NA | ||
| glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / TOPICAL | 2.5 %w/w | ||
| propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CREAM / TOPICAL | 6 mg | ||
| octyldodecanol | OCTYLDODECANOL | 461N1O614Y | SYSTEM / TRANSDERMAL | 4.05 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2efa3d8e-6446-f6c7-e063-6394a90a307e | 27c5d54b-7a41-4cd1-b373-1bdad4231f31 | 2025-02-25 | Warnings | 27c5d54b-7a41-4cd1-b373-1bdad4231f31 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.